These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides. Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Mah HD; Karle JM; Yagi H; Jerina DM; Conney AH Cancer Res; 1979 Oct; 39(10):4069-77. PubMed ID: 383279 [No Abstract] [Full Text] [Related]
5. Tumor initiating activity of 5,11-dimethylchrysene and the structural requirements favoring carcinogenicity of methylated polynuclear aromatic hydrocarbons. Hecht SS; Amin S; Rivenson A; Hoffmann D Cancer Lett; 1979 Nov; 8(1):65-70. PubMed ID: 509421 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test. Coombs MM; Dixon C; Kissonerghis AM Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712 [TBL] [Abstract][Full Text] [Related]
11. Exceptionally high tumor-initiating activity of benzo(c)phenanthrene bay-region diol-epoxides on mouse skin. Levin W; Wood AW; Chang RL; Ittah Y; Croisy-Delcey M; Yagi H; Jerina DM; Conney AH Cancer Res; 1980 Nov; 40(11):3910-4. PubMed ID: 7471042 [No Abstract] [Full Text] [Related]
12. Mutagenicity of polycyclic hydrocarbons. II. Monitoring genetical hazards of chrysene in vitro and vivo. Basler A; Herbold B; Peter S; Röhrborn G Mutat Res; 1977 Apr; 48(2):249-54. PubMed ID: 327309 [TBL] [Abstract][Full Text] [Related]
13. Comparative tumor initiating activities of cyclopentano and methyl derivatives of 5-methylchrysene and chrysene. Amin S; Hecht SS; Di Raddo P; Harvey RG Cancer Lett; 1990 May; 51(1):17-20. PubMed ID: 2337893 [TBL] [Abstract][Full Text] [Related]
14. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene. Amin S; Juchatz A; Furuya K; Hecht SS Carcinogenesis; 1981; 2(10):1027-32. PubMed ID: 7296756 [TBL] [Abstract][Full Text] [Related]
15. Chrysene and methylchrysenes: presence in tobacco smoke and carcinogenicity. Hecht SS; Bondinell WE; Hoffmann D J Natl Cancer Inst; 1974 Oct; 53(4):1121-33. PubMed ID: 4427391 [No Abstract] [Full Text] [Related]
17. Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen. Levin W; Wood AW; Chang RL; Yagi H; Mah HD; Jerina DM; Conney AH Cancer Res; 1978 Jun; 38(6):1831-4. PubMed ID: 647691 [TBL] [Abstract][Full Text] [Related]
18. Tumorigenicity of bay-region epoxides and other derivatives of chrysene and phenanthrene in newborn mice. Buening MK; Levin W; Karle JM; Yagi H; Jerina DM; Conney AH Cancer Res; 1979 Dec; 39(12):5063-8. PubMed ID: 498133 [No Abstract] [Full Text] [Related]
19. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene. Hecht SS; Rivenson A; Hoffmann D Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979 [TBL] [Abstract][Full Text] [Related]
20. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin. Hecht SS; Radok L; Amin S; Huie K; Melikian AA; Hoffmann D; Pataki J; Harvey RG Cancer Res; 1985 Apr; 45(4):1449-52. PubMed ID: 3838497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]